Aminodeoxykanamycin en es it fr

Aminodeoxykanamycin Brand names, Aminodeoxykanamycin Analogs

Aminodeoxykanamycin Brand Names Mixture

  • No information avaliable

Aminodeoxykanamycin Chemical_Formula


Aminodeoxykanamycin RX_link

Aminodeoxykanamycin fda sheet

Aminodeoxykanamycin msds (material safety sheet)

Aminodeoxykanamycin MSDS

Aminodeoxykanamycin Synthesis Reference

No information avaliable

Aminodeoxykanamycin Molecular Weight

484.499 g/mol

Aminodeoxykanamycin Melting Point

No information avaliable

Aminodeoxykanamycin H2O Solubility

No information avaliable

Aminodeoxykanamycin State


Aminodeoxykanamycin LogP


Aminodeoxykanamycin Dosage Forms

No information avaliable

Aminodeoxykanamycin Indication

For treatment of infections where one or more of the following are the known or suspected pathogens: E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species.

Aminodeoxykanamycin Pharmacology

Kanamycin is an aminoglycoside antibiotic. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth. Aminoglycosides are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, but other types of antibiotics are more potent and less damaging to the host. In the past the aminoglycosides have been used in conjunction with penicillin-related antibiotics in streptococcal infections for their synergistic effects, particularly in endocarditis. Aminoglycosides are mostly ineffective against anaerobic bacteria, fungi and viruses.

Aminodeoxykanamycin Absorption

No information avaliable

Aminodeoxykanamycin side effects and Toxicity

LD 50 - ORAL, MOUSE = 17500 MG/KG, LD 50 - ORAL, RAT = >4 GM/KG, LD 50 - ORAL, RABBIT = >3 GM/KG

Aminodeoxykanamycin Patient Information

No information avaliable

Aminodeoxykanamycin Organisms Affected

Enteric bacteria and other eubacteria